Description
BAY-1251152 is an inhibitor of PTEFb/CDK9. PTEFb contributes to the regulation of gene transcription and can be over-expressed in cancer cells, leading to the transcription of key tumor-promoting genes and proliferation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
BAY-1251152 is an inhibitor of PTEFb/CDK9. PTEFb contributes to the regulation of gene transcription and can be over-expressed in cancer cells, leading to the transcription of key tumor-promoting genes and proliferation.
| Cas No. | 1610358-56-9 |
|---|---|
| Purity | ≥98% |
| Formula | C19H18F2N4O2S |
| Formula Wt. | 404.44 |
| IUPAC Name | 5-Fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]-2-pyridinyl}-2-pyridinamine |
| Synonym | BAY 1251152, BAY1251152 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Luecking U., Scholz A., et al. Identification of potent and highly selective PTEFb inhibitor BAY 1251152 for the treatment of cancer: from p.o. to i.v. application via scaffold hops. Cancer Res. 77(13 Suppl):Abstract nr 984 (2017).
Statin; HMG-CoA reductase inhibitor.
β2-adrenergic agonist.
p110γ PI3K inhibitor, potential TRPC1/5/6 nega...
Antioxidant.
Fibrate; PPARα agonist.
PI3K inhibitor.
RET, EGFR, VEGFR2 inhibitor.
Synthetic glycyrrhetinic acid derivative; 11β-...
Naturally sourced ITC, sulfonyl analog of sulfo...
Anthraquinone found in various plant sources; C...
Corticosteroid
GPR17 agonist, NMDA and fructose 1,6-bisphospha...
Fluoroquinolone; topoisomerase IV and bacterial...
Mcl-1 inhibitor
Synthetic steroid hormone; AR agonist, ER and P...
NSAID; COX-1/2 inhibitor.
Synthetic type II pyrethroid insecticide; prote...
Synthetic compound related to sulforaphane.
DP1 antagonist.
Ellagic acid derivative produced by gut microfl...